Life Sciences Software Giant Bets Big on Embedded AI as Investor Caution Grows
Veeva Systems expands AI-powered clinical and regulatory tools across 175+ biotech clients, but analysts project margin compression and potential downside ahead.
Clinical Trials Get a 24-Hour AI Makeover: Veeva's New Agent Slashes Setup Time from Weeks to One Day
Life sciences software giant deploys Anthropic's Claude to automate trial configuration, offering the technology free to existing customers starting December 2024.
Eli Lilly Bets on Veeva's AI Agents to Power Global GLP-1 Commercial Blitz
As Lilly's revenue surges 48% on blockbuster obesity drugs, the pharma giant commits to deploying Veeva's \"agentic commercial\" AI framework worldwide to manage field engagement at unprecedented scale.
Federal Regulators Target Healthcare's Biggest Data Gatekeeper as Epic Systems Faces Antitrust Probe
The FTC and state attorneys general are investigating whether the electronic health records giant—controlling access to 82% of Americans' medical data—is using its market dominance to crush AI competitors and lock in customers.